Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical administration for skin fibrosis in patients with systemic sclerosis - ND Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical ad ...
Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical administration for skin fibrosis in patients with systemic sclerosis - ND Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical ad ...
Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical administration for skin fibrosis in patients with systemic sclerosis.Az ISD002-P144-07 vizsgálat nyílt kiterjesztése P144-gyel kezelt, szisztémás szklerózisban szenvedo betegek felületi borfibrózisának kezelésében. - OLE Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical ad ...
Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical administration for skin fibrosis in patients with systemic sclerosis.Az ISD002-P144-07 vizsgálat nyílt kiterjesztése P144-gyel kezelt, szisztémás szklerózisban szenvedo betegek felületi borfibrózisának kezelésében. - OLE Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical ad ...
Skin fibrosis in patients with systemic sclerosis.Szisztémás szklerózisban szenvedo betegek. MedDRA version: 9.1;Level: LLT;Classification code 10039710;Term: Scleroderma Skin fibrosis in patients with systemic sclerosis.Szisztémás szklerózisban szenvedo betegek. MedDRA ...